Gemcitabine and ATR Inhibitors Synergize to Kill PDAC Cells by Blocking DNA Damage Response

0
17
Investigators phenotypically screened 13 human PDAC cell lines against gemcitabine in combination with 146 clinical inhibitors and observed strong synergy for the ATR kinase inhibitor elimusertib in most cell lines.
[Molecular Systems Biology]
Full ArticleGraphical Abstract